Seroba Life Sciences is a Dublin-based venture capital firm founded in 2002 that specializes in backing innovative. See sector focus and contact routes.
Seroba Life Sciences is a Dublin-based venture capital firm founded in 2002 that specializes in backing innovative companies in the biotechnology and medical technology sectors. The firm’s investment thesis targets early-stage life sciences ventures, primarily at Series A and B, with a geographic focus on Western Europe and selective investments in North America. Seroba invests across biotechnology, medical devices, pharmaceuticals, diagnostics, and medtech, aiming to address unmet medical needs and improve patient outcomes. Its fourth fund, Seroba Fund IV, closed at €123 million in February 2024 and is designed to support up to 12 early-stage investments. While specific check sizes and lead/follow behavior are not publicly detailed, the firm provides capital alongside strategic and operational guidance to help translate scientific research into commercial products. Notable portfolio companies include Shorla Oncology, which received FDA approval for its TEPYLUTE breast and ovarian cancer treatment, and the firm has backed nine European tech companies across ten funding rounds totaling €272 million between 2017 and 2025. Seroba distinguishes i
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Dublin.
Investors like Seroba Life Sciences · Full investor directory · Investor access · Company funding database